Mobidiag (private company)
Established in 2000, Mobidiag develops innovative solutions to advance the diagnosis of infectious diseases and serves the European clinical diagnostics market since 2008.
Mobidiag is headquartered in Espoo, Finland, with a subsidiary in Paris, France.
In 2013, Mobidiag merged with a diagnostic platform developer Genewave and a stool-based clinical assay development company Amplidiag, complementing our capabilities in developing and offering industry-leading diagnostic solutions and solidifying our position in the field of molecular diagnostics.
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Investments 20.05M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Mobidiag
| Name | Criteria | |
|---|---|---|
 |
Abzena
60%
|
|
 |
Citryll
60%
|
|
 |
Monocl
50%
|
|
 |
Naru Intelligence
50%
|
|
 |
Sarcura
50%
|
|
|
Achilles Therapeutics
48%
|
|
 |
Adrenomed AG
48%
|
|
 |
AFYX Therapeutics
48%
|
|
|
Algenex
48%
|
|
 |
Alvotech
48%
|
|
Belgium
Switzerland
Estonia
Lithuania
Norway
France
Ireland
Italy
Portugal